Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Happy Valley Medical licenses Ceracor to Edwards Lifesciences

Aug. 6, 2003

Bayer researchers design adenosine A1 receptor agonists for ischemic disorders

Aug. 5, 2003

Resten-NG continues progress in cardiovascular antisense program

Aug. 1, 2003

Positive phase II results for AC-2592 in CHF

July 31, 2003

Improved pulmonary hypertension in sickle cell disease after oral L-arginine supplementation

July 30, 2003

Diovan approved in Switzerland for ACE inhibitor-intolerant heart failure patients

July 29, 2003

First phase of ONTARGET/TRANSCEND program completed

July 29, 2003

Phase II Canadian trial of MC-4232 cleared to begin

July 28, 2003

Cholesterol management vaccine is a feasible human therapy

July 25, 2003

ALT-711 shows efficacy but fails to meet endpoints in SAPPHIRE and SILVER trials

July 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...